# A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout

> **NCT01736514** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Taiwan, Inc.** · enrollment: 109 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** febuxostat
- **DRUG:** Allopurinol

## Key facts

- **NCT ID:** NCT01736514
- **Lead sponsor:** Astellas Pharma Taiwan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736514, "A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01736514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*